Cancer

Learn how scientists have used Mabtech solutions in their cancer research. From evaluating novel cancer vaccines to screening tumor-infiltrating lymphocytes or CAR T cells, see how Mabtech ELISpot, FluoroSpot, and ELISA can answer your research questions and help bring your immunotherapy to market.

Highlighted research, Published February 23, 2024

Immunotherapy evaluation with immunoassays
Explore the critical role of ELISpot and FluoroSpot assays in immunotherapy and cell and gene therapy, empowering research and development with sensitive potency assays in line with FDA guidelines.

Highlighted research, Published October 13, 2023

White paper: ELISpot in cancer research
ELISpot and FluoroSpot assays are used to study rare cells in cancer research. Our white paper "ELISpot in cancer research" provides an overview of their application in various cancer studies.

Highlighted research, Published September 20, 2018

ELISpot instrumental in finding breast cancer-reactive T cell clones
The authors sequenced breast cancer lesion for somatic mutations, and subsequently screened TILs for reactivity to identify neoantigens using Mabtech IFN-γ ELISpot.

Highlighted research, Published January 22, 2024

Using ELISpot to evaluate personalized RNA neoantigen vaccines in pancreatic cancer
Explore how Mabtech’s ELISpot Pro: Human IFN-γ, kits contributed to cutting-edge cancer vaccine research, as demonstrated in a recent study on personalized RNA neoantigen vaccines in pancreatic cancer.

Behind the scenes, Published May 10, 2023

Webinar recording: Immunotherapy and ELISpot
Attend our webinar on May 17 to find out how immunotherapies have revolutionized cancer treatments. Our Application Specialist, Esther, will explain how ELISpot and FluoroSpot can be used to investigate TILs and CAR T cells.

Highlighted research, Published December 10, 2018

2018 Nobel laureate used Mabtech ELISpot
Nobel laureate Professor James P. Allison has been using Mabtech ELISpot: human IFN-γ throughout his research career.